Changeflow GovPing Pharma & Healthcare Observational Trial of Deep Learning Model for ...
Routine Notice Added Final

Observational Trial of Deep Learning Model for Head and Neck Cancer Prognosis

Favicon for changeflow.com ClinicalTrials.gov Studies
Published
Detected
Email

Summary

NIH registered NCT07532928, an observational study developing a dynamic deep learning model using multimodal patient data to assess prognostic risk and recommend individualized adjuvant treatment for locally advanced head and neck squamous cell carcinoma. The model aims to assist clinicians in precision therapy decisions. The study is observational with an estimated enrollment of 500 participants, registered April 16, 2026.

Published by NIH on changeflow.com . Detected, standardized, and enriched by GovPing. Review our methodology and editorial standards .

What changed

NIH registered a new observational clinical trial on ClinicalTrials.gov under NCT07532928. The study will develop a bidirectional deep learning model using multimodal data to assess prognostic risk in patients with locally advanced head and neck squamous cell carcinoma and recommend individualized postoperative adjuvant treatment or follow-up regimens. The study aims to achieve precision therapy and provide scientific evidence for adjuvant therapy selection decisions.

This registry entry is informational and does not create immediate compliance obligations for regulated entities. Healthcare organizations and research institutions monitoring clinical trial pipelines for competitive intelligence or research collaboration opportunities may track this study. Patients and clinical investigators can access detailed protocol information through ClinicalTrials.gov using NCT07532928. The registry entry itself does not impose new regulatory requirements on any party.

Archived snapshot

Apr 16, 2026

GovPing captured this document from the original source. If the source has since changed or been removed, this is the text as it existed at that time.

← ClinicalTrials.gov Studies

A Bidirectional Study of Individualized Postoperative Adjuvant Treatment Decision Model for Locally Advanced Head and Neck Squamous Cell Carcinoma Based on Multimodal Dynamic Data

Observational NCT07532928 Kind: OBSERVATIONAL Apr 16, 2026

Abstract

Based on multimodal data, we establish a dynamic deep learning model to conduct prognostic risk assessment for patients and recommend the 'most suitable' treatment/follow-up regimen after radical treatment, assisting clinicians in improving homogenized evaluation levels and achieving individualized precision therapy, thereby providing scientific evidence for the currently widely debated selection of postoperative adjuvant therapy in locally advanced head and neck squamous cell carcinoma patients.

Conditions: Deep Learning, Head & Neck Squamous Cell Carcinoma

View original document →

Get daily alerts for ClinicalTrials.gov Studies

Daily digest delivered to your inbox.

Free. Unsubscribe anytime.

About this page

What is GovPing?

Every important government, regulator, and court update from around the world. One place. Real-time. Free. Our mission

What's from the agency?

Source document text, dates, docket IDs, and authority are extracted directly from NIH.

What's AI-generated?

The summary, classification, recommended actions, deadlines, and penalty information are AI-generated from the original text and may contain errors. Always verify against the source document.

Last updated

Classification

Agency
NIH
Published
April 16th, 2026
Instrument
Notice
Legal weight
Non-binding
Stage
Final
Change scope
Minor
Document ID
NCT07532928

Who this affects

Applies to
Healthcare providers Patients Clinical investigators
Industry sector
6211 Healthcare Providers
Activity scope
Clinical trial registration Medical AI development Cancer research
Geographic scope
United States US

Taxonomy

Primary area
Healthcare
Operational domain
Clinical Operations
Topics
Artificial Intelligence Public Health

Get alerts for this source

We'll email you when ClinicalTrials.gov Studies publishes new changes.

Free. Unsubscribe anytime.

You're subscribed!